Inmunología, Oftalmología y ORL
Departamento
University Medical Center Hamburg-Eppendorf
Hamburgo, AlemaniaPublicaciones en colaboración con investigadores/as de University Medical Center Hamburg-Eppendorf (11)
2024
-
Survival in primary hemophagocytic lymphohistiocytosis, 2016 to 2021: etoposide is better than its reputation
Blood, Vol. 143, Núm. 10, pp. 872-881
2023
-
A second update on mapping the human genetic architecture of COVID-19
Nature
-
Advancing with cancer immunotherapeutics: CD29+ regulatory T cell antagonism
Gut
-
Correction: “The 5th edition of The World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms” Leukemia. 2022 Jul;36(7):1720–1748 (Leukemia, (2022), 36, 7, (1720-1748), 10.1038/s41375-022-01620-2)
Leukemia
2021
-
Guidelines for the use of flow cytometry and cell sorting in immunological studies (third edition)
European Journal of Immunology, Vol. 51, Núm. 12, pp. 2708-3145
2020
-
Characterization of the clinical and immunologic phenotype and management of 157 individuals with 56 distinct heterozygous NFKB1 mutations
Journal of Allergy and Clinical Immunology, Vol. 146, Núm. 4, pp. 901-911
-
The nucleus acts as a ruler tailoring cell responses to spatial constraints
Science, Vol. 370, Núm. 6514
2019
-
Recommendations for the management of hemophagocytic lymphohistiocytosis in adults
Blood, Vol. 133, Núm. 23, pp. 2465-2477
2005
2002
-
The family of toxin-related ecto-ADP-ribosyltransferases in humans and the mouse
Protein Science, Vol. 11, Núm. 7, pp. 1657-1670
2001
-
ADP-ribosyltransferases: Plastic tools for inactivating protein and small molecular weight targets
Journal of Biotechnology, Vol. 92, Núm. 2, pp. 81-87